Net Loss per Share - Antidilutive effect (Details) - shares	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022
Net Loss per Share
Potentially dilutive common stock equivalents outstanding	4,735,560	3,679,468
Options issued and outstanding
Net Loss per Share
Potentially dilutive common stock equivalents outstanding	4,213,405	3,679,468
Restricted Stock Units
Net Loss per Share
Potentially dilutive common stock equivalents outstanding	522,155

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration